Hyderabad: A high level United States of America delegation, led by the Chief Operating Officer of US International Development Finance Corporation (DFC) David Marchick will visit Hyderabad shortly as part of its tour to advance DFC investments helping boost global health and expand Covid-19 vaccine production capacity.
The delegation will participate in a signing ceremony to open a new facility with substantial capacity for vaccine manufacturing. This work is in support of the historic commitment set out by President Biden and his counterparts in the “Quad” – Australia, India, Japan and the United States.
DFC’s financial tools are driving growth in vaccine manufacturing capacity in multiple regions, with multiple technologies and within large and small countries.
Already, DFC’s support is projected to facilitate capacity expansion to produce nearly two billion Covid-19 vaccine doses across the globe by the end of 2022, with more projects in the pipeline.
The agency is also working on expanding access to critical therapeutics and introducing medical equipment designed for low resource environments.